Last edition
News about "regenerative medicine"
Syntax Bio and Mayo Clinic Partner on Type 1 Diabetes Cell Therapy
Syntax Bio and Mayo Clinic have partnered to accelerate the development of stem cell-derived pancreatic cell therapies for Type 1 Diabetes (T1D). The collaboration aims to advance regenerative medicine approaches that could restore insulin-producing cells.
Regenerative Medicine | 10/06/2026 | By News Bureau
OrganaBio Acquires Excellos Assets to Establish Bicoastal Cell Therapy Manufacturing Platform
The acquisition expands cGMP manufacturing, PBMC isolation and cryopreservation capabilities across the US to support cell therapy developers from preclinical to commercial stages.
Regenerative Medicine | 16/05/2026 | By News Bureau
Promocell Enters GMP Field with Launch of Custom Cell Culture Media Services
PromoCell GmbH has announced its entry into the Good Manufacturing Practice (GMP) field with the launch of custom cell culture media services designed specifically for cell-based therapy and regenerative medicine.
Regenerative Medicine | 01/10/2025 | By Dineshwori | 295
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy